Europe Fundus Cameras Market Forecast to 2030 - Regional Analysis - by Type, Portability, Application, and End User

The Europe fundus cameras market was valued at US$ 184.87 million in 2022 and is expected to reach US$ 337.55 million by 2030; it is estimated to grow at a CAGR of 7.8% from 2022 to 2030.

Launches of Innovative Products Fuel the Europe Fundus Cameras Market

Medical device companies focus on the development and launch of new products, along with obtaining approvals from corresponding regulatory bodies. A few of the recent developments fostering the global fundus market are mentioned below.

In October 2021, NIDEK CO., LTD. announced the launch of "Retina Scan Duo 2," a combined optical coherence tomography (OCT) and fundus camera system. The newly launched product aids in enhanced eye screening and clinical efficiency with user-friendly features. Retina Scan Duo 2 incorporates a novel image enhancement technique that generates an HD image from a single-frame image, ensuring great patient comfort. In January 2023, Topcon Healthcare, a leading provider of medical devices and software solutions, announced the launch of "NW500," a user-friendly, robotic fundus camera ensuring to deliver reliable and sharp-quality images. The new product also enables a streamlined workflow in diagnostic laboratories, enhancing the patient experience and allowing the screening personnel to acquire retinal images in well-lit settings. Moreover, they don't need to ask patients to dilate their eyes. Further, the product provides excellent-quality color fundus images across the three traditional fixation points (disc, center, and macula) and the nine fixation positions for peripheral photography. In June 2021, Coburn Technologies announced the launch of the HFC-1 Non-Mydriatic Fundus Camera, a new retinal camera manufactured by Huvitz, Co., Ltd. With a highly accurate autodetection technology, the products are intended to produce sharp, quick, and reliable retinal imaging and measurements.

Europe Fundus Cameras Market Overview

The leading cause of irreversible blindness and severely impaired eyesight-age-related macular degeneration will affect 77 million Europeans by 2050, as per the statistics revealed by the British Journal of Opthalmology. According to the American Academy of Ophthalmology 2023 report, 3%-4.1% of Europeans are affected by diabetic retinopathy owing to rising type 2 diabetes. For instance, the UK, 43.3%; Switzerland, 42.3%; Poland, 31.8%; and Germany accounting, 29.9%, accounting for actual incidence. Additionally, the World Health Organization (WHO) reports Scotland has faced an increase in the number of people suffering from diabetes. Moreover, the UK is the largest country in the Europe region with nationwide screening for all patients suffering from DM above the age of 12 years, comprising 9 million patients in total, accounting for 6% of the population. Further, rising product approvals in the European region further enhance the adoption of the US fundus camera market. For records, in August 2022, Formycon AG ("Formycon"), Polpharma Biologics Group BV ("Polpharma Biologics"), and Bioeq AG ("Bioeq") announced that the European Commission (EU) granted marketing authorization for "Ranivisio" (Ranivisio - Ranibizumab), biosimilar to Lucentis intended to treat several serious retinal diseases in the European Union (EU). Such aforementioned factors will enhance the adoption of fundus camera in the European region thereby dominating the market growth during 2022-2030.

Europ

e Fundus Cameras Market Revenue and Forecast to 2030 (US$ Million)

Europe Fundus Cameras Market Segmentation

The Europe fundus cameras market is segmented based on type, portability, application, end user, and country.

Based on type, the Europe fundus cameras market is segmented into mydriatic fundus camera, non-mydriatic fundus camera, hybrid fundus camera, and ROP fundus camera. The non-mydriatic fundus camera segment held the largest market share in 2022.

Based on portability, the Europe fundus cameras market is bifurcated into handheld and tabletop. The tabletop segment held a larger market share in 2022.

Based on application, the Europe fundus cameras market is segmented into diabetic retinopathy, age-related macular degeneration, retinal vascular disorders, and others. The diabetic retinopathy segment held the largest market share in 2022.

Based on end user, the Europe fundus cameras market is segmented into hospitals, ophthalmology centers, and others. The hospitals segment held the largest market share in 2022.

Based on country, the Europe fundus cameras market is segmented into the UK, Germany, France, Italy, Spain, and the Rest of Europe. Germany dominated the Europe fundus cameras market share in 2022.

Nikon Corp, Topcon Corp, NIDEK CO LTD, Canon Inc, Carl Zeiss AG, Visionix USA Inc, Kowa Co Ltd, CenterVue SpA, Volk Optical Inc, and Digital Eye Center are some of the leading players operating in the Europe fundus cameras market.

Reasons to Buy

• Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the Europe fundus camera market.
• Highlights key business priorities in order to assist companies to realign their business strategies
• The key findings and recommendations highlight crucial progressive industry trends in the Europe fundus camera market, thereby allowing players across the value chain to develop effective long-term strategies
• Develop/modify business expansion plans by using substantial growth offering developed and emerging markets
• Scrutinize in-depth Europe market trends and outlook coupled with the factors driving the Europe fundus camera market, as well as those hindering it
• Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing, and distribution